FindTrial
Sign In

A Clinical Study to compare the Efficacy of Nashtapushpantaka Rasa and Rajahpravartini Vati in the treatment of Artavakshaya in females of Polycystic Ovarian Syndrome

A Randomized Comparative Clinical Study to Evaluate the Efficacy of Nashtapushpantaka Rasa and Rajahpravartini Vati in the management of Artavakshaya in Polycystic Ovarian Syndrome - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084467
Enrollment
134
Registered
2025-04-09
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N914- Secondary oligomenorrhea

Interventions

None listed

Sponsors

Mamta Rani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Females having PCOS assessed on Rotterdam criteria -2outof3 -oligo-and or anovulation -clinical and or biochemical signs of hyperandrogenism -polycystic ovaries in USG Patient is ready to provide signed informed consent

Exclusion criteria

Exclusion criteria: PCOS with heavy menstrual bleeding or menorrhagia or metrorrhagia. Females less than 18 yrs. and more than 40 yrs. of age. Females having primary amenorrhea. Females having physiological secondary amenorrhea due to lactation. Females with any organic pelvic lesions like fibroid uterus, adenomyosis, PID etc. Females with hypo and hyper thyroidism. Patients with chronic systemic illness. Patients using oral contraceptive pills.

Design outcomes

Primary

MeasureTime frame
Changes in Menstrual cycle length intermenstrual period amount and quality of bleeding. In USG changes in ovarian volume and polycystic appearance of ovary. Changes in hormone levels serum FSH LH LH FSH ratio Prolactin testosterone etc Timepoint: baseline and after 99 days—

Secondary

MeasureTime frame
Changes in hirsutism based on Ferriman- Gallway score. Changes in Quality of Life using PCOS-Qol Scale. Timepoint: baseline and after 99 days—

Countries

India

Contacts

Public ContactDr Gati Krushna Panda

Institute of Ayurveda Studies & Research SKAU Kurukshetra

drjk67@gmail.com9896033056

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026